Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Institute for Genome Sciences Awarded NIAID Grant

Published: Friday, July 04, 2014
Last Updated: Friday, July 04, 2014
Bookmark and Share
$15.2M NIAID grant on infectious disease research.

The Institute for Genome Sciences (IGS) at the University of Maryland School of Medicine (UMSOM) has received a grant award of $15.2 million over five years from the National Institute of Allergy and Infectious Diseases (NIAID) to create a research center to apply genomic techniques to the study of pathogens and their hosts, and to expand understanding of the ways that pathogens can cause harm.

The IGS Genome Center for Infectious Diseases (GCID) will use large-scale genomics and bioinformatics approaches to investigate pathogen biology, virulence, drug resistance, immune invasion, host-microbiome interactions, and pathogen resistance. Specialized tracks will focus on host/pathogen interrelationships for bacteria, fungi, and parasites.

An interdisciplinary team will be leading the GCID research, including internationally recognized faculty from the Institute for Genome Sciences, the Department of Microbiology and Immunology and the Center for Vaccine Development at UMSOM. The uniquely qualified team includes investigators with extensive contacts within national and international infectious disease communities, whose previous research collaborations have involved a wide range of human pathogens.

“This team has been in the forefront of applying genomic techniques to advance scientific understanding of infectious disease agents, and the NIAID grant will catalyze further development of genomics approaches within global infectious disease communities,” said Claire Fraser, PhD, Director of the Institute for Genome Sciences, and professor of Medicine and Microbiology and Immunology at the UMSOM.

“Integrating genomics with diagnostic and clinical medicine has advanced our biological understanding of diseases and health,” says E. Albert Reece, MD, PhD, MBA, vice president for medical affairs at the University of Maryland, and John Z. and Akiko K. Bowers distinguished professor and dean of the University of Maryland School of Medicine. “The NIAID grant will foster new collaborations across disciplines within the clinical and research centers in the School of Medicine, as well as within international infectious disease communities.”

The grant, “Host, Pathogen, and the Microbiome: Determinants of Infectious Disease Outcome” will be led by Claire Fraser, PhD, as Principal Investigator and Administrative Core Director, and Drs. David Rasko and Owen White, will be team Principal Investigators.

The funding will support a technology core, a data management core, an immunology core, and an administrative core, as well as research programs that focus on three areas: host/ bacterial pathogens and the microbiome, led by David Rasko, PhD; the genomic analysis of fungal pathogenesis, led by Vincent Bruno, PhD; and integrated genomics research in parasitic tropical diseases led by Joana C. Silva, PhD and Julie C. Dunning Hotopp, PhD.

The projects will include whole genome and targeted genome sequencing, transcriptome profiling by RNA-seq, rRNA community profiling, and metagenomics and metatranscriptomic sequencing. The sequencing will be performed using three platforms, including the Illumina MiSeq and HiSeq, and the Pacific Biosciences RSH system.

In addition to vital research projects, IGS will establish workshops and continue educational initiatives to expand the understanding of how to apply genomics to high priority research questions that impact global health.

IGS has previously received grants as a Genome Sequencing Center for Infectious Diseases (GSCID), an NIAID-funded five year contract, and the lead investigators have also had Principal Investigator roles with the NIAID-funded Microbial Sequencing Center (MSC), a five year contract.

This U19 grant will run for five years until 2019.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!